Jacks Lee

This profile gathers the share dealings of Jacks Lee across 2 companies, led by G1 Therapeutics, Inc. and Vaxcyte, Inc. In total, 5 filings cover trades dated from 15 June 2023 to 12 June 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 16 June 2025 with a share grant in Vaxcyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.